| | 75659-07-3 Basic information More.. |
| Product Name: | DILEVALOL | | Synonyms: | 2-Hydroxy-5-[(R)-1-hydroxy-2-[[(R)-1-methyl-3-phenylpropyl]amino]ethyl]benzamide;Sch-19927;(-)-5-((1R)-1-Hydroxy-2-((1R)-1-methyl-3-phenylpropylamino)ethyl)salicylamid [iupac];(R,R)-Labetalol;2-Hydroxy-5-((1R)-1-hydroxy-2-(((1R)-1-methyl-3-phenylpropyl)amino)ethyl)benzamide;Benzamide, 2-hydroxy-5-((1R)-1-hydroxy-2-(((1R)-1-methyl-3-phenylpropyl)amino)ethyl)-;DILEVALOL;DILEVALOL HCL | | CAS: | 75659-07-3 | | MF: | C19H24N2O3 | | MW: | 328.41 | | EINECS: | | | Mol File: | 75659-07-3.mol |  |
Use
Dilevalol is a "dual-mechanism" antihypertensive reportedly suitable for a wide range of
patients. Its partial beta2-agonist action is expected to induce vasodilation, whereas its
beta1-antagonist component may protect against stress-induced hemodynamic charges
without altering the cardiac output. Dilevalol is the R,R-isomer of labetalol.
- Dilevalol
-
- US $1520.00-1980.00 / mg
- 2024-10-28
- CAS:75659-07-3
- Min. Order:
- Purity:
- Supply Ability: 10g
|
|
75659-07-3
Recommend Suppliers |
|